In light of recent global shocks and rising external volatility, there is a growing need to effectively monitor short-term ...

Clinical trials for a new drug can take years to complete, and cost up to hundreds of millions of dollars. New draft guidance from the U.S. Food and Drug Administration aims to make that process ...

In this video interview, David Morton, PhD, director of biostatistics at Certara, explores the practical challenges of implementing Bayesian designs, including the need for simulation, ...

As rare disease trials face persistent feasibility challenges, Bayesian designs are gaining momentum by enabling more flexible, data-driven approaches that integrate prior knowledge, reduce sample ...

From advances in artificial intelligence and blockchain to precision agriculture, statistical innovation drives progress and bolsters U.S. competitiveness. Data underpins science in every field and ...

The FDA’s new draft guidance on Bayesian methods in clinical trials has been hailed by some as a breakthrough that could speed drug development. But statisticians and researchers are divided on ...

Abstract: Bayesian inference provides a methodology for parameter estimation and uncertainty quantification in machine learning and deep learning methods. Variational inference and Markov Chain ...

Marty Makary was appointed commissioner of the Food and Drug Administration (FDA) in 2025. The prominent surgeon, medical researcher, bestselling author, and critic of the medical ...

Bayesian analysis is being used with increasing frequency in critical care research and brings advantages and disadvantages compared to traditional Frequentist techniques. This study overviews this ...

The course is part of Mathematical Sciences, Master's Programme, University of Gothenburg, but is also open for students outside the program who meet the course prerequisites. The course can be part ...

In recent years, something unexpected has been happening in artificial intelligence. Modern AI appears to be breaking a rule that statisticians have preached for nearly a century: Keep models in a ...